-
2
-
-
84861610591
-
Immunocytokines: A novel class of potent armed antibodies
-
Pasche N, Neri D. Immunocytokines: a novel class of potent armed antibodies. Drug Discov Today. 2012;17:583-590.
-
(2012)
Drug Discov Today
, vol.17
, pp. 583-590
-
-
Pasche, N.1
Neri, D.2
-
3
-
-
84896925253
-
Emerging classes of armed antibody therapeutics against cancer
-
Hess C, Venetz D, Neri D. Emerging classes of armed antibody therapeutics against cancer. Medchemcomm. 2014;5:408-431.
-
(2014)
Medchemcomm
, vol.5
, pp. 408-431
-
-
Hess, C.1
Venetz, D.2
Neri, D.3
-
4
-
-
0038283161
-
Interleukin-10 therapy - Review of a new approach
-
Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy - review of a new approach. Pharmacol Rev. 2003;55:241-269.
-
(2003)
Pharmacol Rev
, vol.55
, pp. 241-269
-
-
Asadullah, K.1
Sterry, W.2
Volk, H.D.3
-
5
-
-
84866386408
-
IL-33 attenuates development and perpetuation of chronic intestinal inflammation
-
Grobeta P, Doser K, Falk W, et al. IL-33 attenuates development and perpetuation of chronic intestinal inflammation. Inflamm Bowel Dis. 2012;18:1900-1909.
-
(2012)
Inflamm Bowel Dis
, vol.18
, pp. 1900-1909
-
-
Grobeta, P.1
Doser, K.2
Falk, W.3
-
6
-
-
80054856034
-
Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis
-
Wirtz S, Billmeier U, McHedlidze T, et al. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology. 2011;141:1875-1886.
-
(2011)
Gastroenterology
, vol.141
, pp. 1875-1886
-
-
Wirtz, S.1
Billmeier, U.2
McHedlidze, T.3
-
7
-
-
0029835760
-
Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats
-
Qiu BS, Pfeiffer CJ, Keith JC Jr. Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. Dig Dis Sci. 1996;41:1625-1630.
-
(1996)
Dig Dis Sci
, vol.41
, pp. 1625-1630
-
-
Qiu, B.S.1
Pfeiffer, C.J.2
Keith, J.C.3
-
8
-
-
33847286913
-
Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis
-
Trachsel E, Bootz F, Silacci M, et al. Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis. Arthritis Res Ther. 2007;9:R9.
-
(2007)
Arthritis Res Ther
, vol.9
, pp. R9
-
-
Trachsel, E.1
Bootz, F.2
Silacci, M.3
-
9
-
-
75649113035
-
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis
-
Schwager K, Kaspar M, Bootz F, et al. Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis. Arthritis Res Ther. 2009;11:R142.
-
(2009)
Arthritis Res Ther
, vol.11
, pp. R142
-
-
Schwager, K.1
Kaspar, M.2
Bootz, F.3
-
10
-
-
84884603722
-
Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse
-
Doll F, Schwager K, Hemmerle T, et al. Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse. Arthritis Res Ther. 2013;15:R138.
-
(2013)
Arthritis Res Ther
, vol.15
, pp. R138
-
-
Doll, F.1
Schwager, K.2
Hemmerle, T.3
-
11
-
-
80051947187
-
The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model
-
Schwager K, Bootz F, Imesch P, et al. The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model. Hum Reprod. 2011;26:2344-2352.
-
(2011)
Hum Reprod
, vol.26
, pp. 2344-2352
-
-
Schwager, K.1
Bootz, F.2
Imesch, P.3
-
12
-
-
84977986202
-
A Phase IB clinical trial in rheumatoid arthritis of DEKAVIL (F8-IL10), a novcel anti-inflammatory immunocytokine
-
Galeazzi M, Bazzichi L, Sebastiani G, et al. A Phase IB clinical trial in rheumatoid arthritis of DEKAVIL (F8-IL10), a novcel anti-inflammatory immunocytokine. Ann Rheum Dis. 2014:73(suppl 2).
-
(2014)
Ann Rheum Dis
, vol.73
-
-
Galeazzi, M.1
Bazzichi, L.2
Sebastiani, G.3
-
13
-
-
84906309157
-
Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis
-
Hemmerle T, Doll F, Neri D. Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis. Proc Natl Acad Sci U S A. 2014;111:12008-12012.
-
(2014)
Proc Natl Acad Sci U S A
, vol.111
, pp. 12008-12012
-
-
Hemmerle, T.1
Doll, F.2
Neri, D.3
-
14
-
-
84908054079
-
Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation
-
Hemmerle T, Zgraggen S, Matasci M, et al. Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation. J Dermatol Sci. 2014;76:96-103.
-
(2014)
J Dermatol Sci
, vol.76
, pp. 96-103
-
-
Hemmerle, T.1
Zgraggen, S.2
Matasci, M.3
-
15
-
-
84938418857
-
The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activity
-
Hess C, Neri D. The antibody-mediated targeted delivery of interleukin-13 to syngeneic murine tumors mediates a potent anticancer activity. Cancer Immunol Immunother. 2015;64:635-644.
-
(2015)
Cancer Immunol Immunother
, vol.64
, pp. 635-644
-
-
Hess, C.1
Neri, D.2
-
16
-
-
42549099073
-
A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo
-
Villa A, Trachsel E, Kaspar M, et al. A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo. Int J Cancer. 2008;122:2405-2413.
-
(2008)
Int J Cancer
, vol.122
, pp. 2405-2413
-
-
Villa, A.1
Trachsel, E.2
Kaspar, M.3
-
17
-
-
84884128485
-
Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia
-
Gutbrodt KL, Schliemann C, Giovannoni L, et al. Antibody-based delivery of interleukin-2 to neovasculature has potent activity against acute myeloid leukemia. Sci Transl Med. 2013;5:201ra118.
-
(2013)
Sci Transl Med
, vol.5
-
-
Gutbrodt, K.L.1
Schliemann, C.2
Giovannoni, L.3
-
18
-
-
74749108259
-
Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: Three clinical-grade fully human antibodies
-
Pedretti M, Rancic Z, Soltermann A, et al. Comparative immunohistochemical staining of atherosclerotic plaques using F16, F8 and L19: three clinical-grade fully human antibodies. Atherosclerosis. 2010;208:382-389.
-
(2010)
Atherosclerosis
, Issue.208
, pp. 382-389
-
-
Pedretti, M.1
Rancic, Z.2
Soltermann, A.3
-
19
-
-
79953766810
-
Antibody-based targeting of interferon-alpha to the tumor neovasculature: A critical evaluation
-
Frey K, Zivanovic A, Schwager K, et al. Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation. Integr Biol (Camb). 2011;3:468-478.
-
(2011)
Integr Biol (Camb)
, vol.3
, pp. 468-478
-
-
Frey, K.1
Zivanovic, A.2
Schwager, K.3
-
20
-
-
79957437540
-
Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7
-
Pasche N, Woytschak J, Wulhfard S, et al. Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7. J Biotechnol. 2011;154:84-92.
-
(2011)
J Biotechnol
, vol.154
, pp. 84-92
-
-
Pasche, N.1
Woytschak, J.2
Wulhfard, S.3
-
21
-
-
84887449396
-
The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer
-
Hemmerle T, Neri D. The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer. Int J Cancer. 2014;134:467-477.
-
(2014)
Int J Cancer
, vol.134
, pp. 467-477
-
-
Hemmerle, T.1
Neri, D.2
-
22
-
-
84901456581
-
Tumor-targeting properties of novel immunocytokines based on murine IL1beta and IL6
-
Hess C, Neri D. Tumor-targeting properties of novel immunocytokines based on murine IL1beta and IL6. Protein Eng Des Sel. 2014;27:207-213.
-
(2014)
Protein Eng Des Sel
, vol.27
, pp. 207-213
-
-
Hess, C.1
Neri, D.2
-
23
-
-
0026059084
-
Human IgA and IgG F(ab′)2 that bind to staphylococcal protein A belong to the VHIII subgroup
-
Sasso EH, Silverman GJ, Mannik M. Human IgA and IgG F(ab′)2 that bind to staphylococcal protein A belong to the VHIII subgroup. J Immunol. 1991;147:1877-1883.
-
(1991)
J Immunol
, vol.147
, pp. 1877-1883
-
-
Sasso, E.H.1
Silverman, G.J.2
Mannik, M.3
-
24
-
-
0027197493
-
"Diabodies": Small bivalent and bispecific antibody fragments
-
Holliger P, Prospero T, Winter G. "Diabodies": small bivalent and bispecific antibody fragments. Proc Natl Acad Sci U S A. 1993;90:6444-6448.
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, pp. 6444-6448
-
-
Holliger, P.1
Prospero, T.2
Winter, G.3
-
25
-
-
0031012127
-
Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo
-
Lieschke GJ, Rao PK, Gately MK, et al. Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo. Nat Biotechnol. 1997;15:35-40.
-
(1997)
Nat Biotechnol
, vol.15
, pp. 35-40
-
-
Lieschke, G.J.1
Rao, P.K.2
Gately, M.K.3
-
26
-
-
34147112902
-
Scalable transient gene expression in Chinese hamster ovary cells in instrumented and non-instrumented cultivation systems
-
Muller N, Derouazi M, Van Tilborgh F, et al. Scalable transient gene expression in Chinese hamster ovary cells in instrumented and non-instrumented cultivation systems. Biotechnol Lett. 2007;29:703-711.
-
(2007)
Biotechnol Lett
, vol.29
, pp. 703-711
-
-
Muller, N.1
Derouazi, M.2
Van Tilborgh, F.3
-
27
-
-
0028967287
-
Mouse interleukin-12 (IL-12) p40 homodimer: A potent IL-12 antagonist
-
Gillessen S, Carvajal D, Ling P, et al. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol. 1995;25:200-206.
-
(1995)
Eur J Immunol
, vol.25
, pp. 200-206
-
-
Gillessen, S.1
Carvajal, D.2
Ling, P.3
-
28
-
-
84866015194
-
Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation
-
Chassaing B, Srinivasan G, Delgado MA, et al. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One. 2012;7:e44328.
-
(2012)
PLoS One
, vol.7
-
-
Chassaing, B.1
Srinivasan, G.2
Delgado, M.A.3
-
29
-
-
84878000134
-
Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectin
-
Franz M, Hilger I, Grun K, et al. Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectin. J Heart Lung Transplant. 2013;32:641-650.
-
(2013)
J Heart Lung Transplant
, vol.32
, pp. 641-650
-
-
Franz, M.1
Hilger, I.2
Grun, K.3
-
30
-
-
79151478660
-
Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies
-
Fiechter M, Frey K, Fugmann T, et al. Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies. Atherosclerosis. 2011;214:325-330.
-
(2011)
Atherosclerosis
, vol.214
, pp. 325-330
-
-
Fiechter, M.1
Frey, K.2
Fugmann, T.3
-
31
-
-
0030065033
-
Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts
-
Pujuguet P, Hammann A, Moutet M, et al. Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol. 1996;148:579-592.
-
(1996)
Am J Pathol
, vol.148
, pp. 579-592
-
-
Pujuguet, P.1
Hammann, A.2
Moutet, M.3
-
32
-
-
0242490282
-
Reduced migration of fibroblasts in inflammatory bowel disease: Role of inflammatory mediators and focal adhesion kinase
-
Leeb SN, Vogl D, Gunckel M, et al. Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase. Gastroenterology. 2003;125:1341-1354.
-
(2003)
Gastroenterology
, vol.125
, pp. 1341-1354
-
-
Leeb, S.N.1
Vogl, D.2
Gunckel, M.3
-
33
-
-
51449108572
-
Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF)
-
Brenmoehl J, Falk W, Goke M, et al. Inflammation modulates fibronectin isoform expression in colonic lamina propria fibroblasts (CLPF). Int J Colorectal Dis. 2008;23:947-955.
-
(2008)
Int J Colorectal Dis
, vol.23
, pp. 947-955
-
-
Brenmoehl, J.1
Falk, W.2
Goke, M.3
-
34
-
-
34547092167
-
Evidence for a differential expression of fibronectin splice forms ED-A and ED-B in Crohn's disease (CD) mucosa
-
Brenmoehl J, Lang M, Hausmann M, et al. Evidence for a differential expression of fibronectin splice forms ED-A and ED-B in Crohn's disease (CD) mucosa. Int J Colorectal Dis. 2007;22:611-623.
-
(2007)
Int J Colorectal Dis
, vol.22
, pp. 611-623
-
-
Brenmoehl, J.1
Lang, M.2
Hausmann, M.3
-
35
-
-
17544399131
-
Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo
-
Gately MK, Carvajal DM, Connaughton SE, et al. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann N Y Acad Sci. 1996;795:1-12.
-
(1996)
Ann N Y Acad Sci
, vol.795
, pp. 1-12
-
-
Gately, M.K.1
Carvajal, D.M.2
Connaughton, S.E.3
-
36
-
-
33644830150
-
The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects
-
Shimozato O, Ugai S, Chiyo M, et al. The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology. 2006;117:22-28.
-
(2006)
Immunology
, vol.117
, pp. 22-28
-
-
Shimozato, O.1
Ugai, S.2
Chiyo, M.3
-
37
-
-
0028819316
-
Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity
-
Ling P, Gately MK, Gubler U, et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol. 1995;154:116-127.
-
(1995)
J Immunol
, vol.154
, pp. 116-127
-
-
Ling, P.1
Gately, M.K.2
Gubler, U.3
-
38
-
-
84864142890
-
Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa
-
Kim DJ, Kim KS, Song MY, et al. Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa. Clin Immunol. 2012;144:190-199.
-
(2012)
Clin Immunol
, vol.144
, pp. 190-199
-
-
Kim, D.J.1
Kim, K.S.2
Song, M.Y.3
-
39
-
-
0028067787
-
Transfer of CD4+ T cells to C. B-17 SCID mice: A model to study Th1 and Th2 cell differentiation and regulation in vivo
-
Powrie F, Coffman RL, Correa-Oliveira R. Transfer of CD4+ T cells to C. B-17 SCID mice: a model to study Th1 and Th2 cell differentiation and regulation in vivo. Res Immunol. 1994;145:347-353.
-
(1994)
Res Immunol
, vol.145
, pp. 347-353
-
-
Powrie, F.1
Coffman, R.L.2
Correa-Oliveira, R.3
|